Clinical trialNACompleted
Evaluation of PET/MRI in Patients With Pancreatic Adenocarcinoma
Evaluation of the Novel Imaging Modality Simultaneous Positron Emission Tomography Magnetic Resonance Imaging (PET/MRI) in Patients With Pancreatic Adenocarcinoma
- Outcome
- Finished, no results posted
- Phase
- NA
- Status
- Completed
- Study type
- Interventional
- Start
- February 2013
- Expected end
- 22 August 2017
- Enrollment
- 25 participants
- Sites
- 1
- Primary outcomes
- PET/MRI compared to conventional CT and MRI
- Sponsor
- Other
- Results posted
- No
- Last update
- 25 June 2018
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
This study will use PET/MRI in patients with adenocarcinoma of the pancreas to identify hidden metastatic disease or identify patients with borderline or locally advanced disease.
Detailed description public domain (ClinicalTrials.gov)
Patients will receive a PET/MRI scan within 6 weeks of their standard of care imaging. There is no maximum number of scans for research. The number of scans depends on each patient's treatment plan.